Not much, other than letting us know what they would like to do and not what they have done to advance the share price. Another grant application about to expire and nothing. Talk of expansion, just a repeat of years ago and nothing. Sale of patents, no luck there. The latest is the net revenue sharing offer. Good to know they are trying different things but their success rate in finding funding has been "0". Either they are approaching the wrong people or the presentation sucks or maybe the N Assay is not all that they proclaim or management doesn't have a clue in how to get product to market. We don't even know what flat pack sales are. The excuse of it being hard to acquire market share is getting a little stale.
News 
Market Data 
Discover 
